NIHSIN-PA
7215PA
NEXGRAM
0096
XOX
0165
TALAMT
2259
GPACKET
0082
(Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 94.19%-265K | -208.77%-6.92M | 99.66%-12.29K | -112.64%-651K | 0.18%-1.69M | -124.95%-4.56M | 75.01%-2.24M | -3.67M | 162.46%5.15M | 40.48%-1.7M |
Net profit before non-cash adjustment | 53.23%-803K | -5.47%-4.77M | -1,093.61%-1.63M | -1.95%-1.52M | 105.92%101K | -44.65%-1.72M | 55.50%-4.52M | ---136.84K | 83.44%-1.49M | 8.28%-1.71M |
Total adjustment of non-cash items | -65.06%152K | -92.22%90.82K | -10.75%393.82K | 51.46%362K | -552.67%-1.1M | 78.28%435K | -10.69%1.17M | --441.23K | -77.50%239K | 129.25%243K |
-Depreciation and amortization | -66.90%144K | -11.07%952.87K | -187.34%-251.13K | 46.30%376K | 50.57%393K | 63.53%435K | -8.92%1.07M | --287.52K | -72.63%257K | 115.70%261K |
-Reversal of impairment losses recognized in profit and loss | 50.00%3K | 311.50%406.04K | 38.89%137.04K | ---2K | --269K | --2K | -34.39%98.67K | --98.67K | ---- | ---- |
-Assets reserve and write-off | ---- | 437.13%373.35K | ---- | ---- | ---- | ---- | -42.18%69.51K | ---- | ---- | ---- |
-Disposal profit | ---- | ---1.6M | --186.03K | ---18K | ---- | ---- | --0 | --0 | ---- | ---- |
-Other non-cash items | 350.00%5K | 41.39%-42.48K | -255.56%-51.48K | 133.33%6K | 127.78%5K | 90.91%-2K | 48.29%-72.48K | ---14.48K | 84.62%-18K | -20.00%-18K |
Changes in working capital | 111.77%386K | -301.20%-2.24M | 130.90%1.23M | -92.08%507K | -198.28%-695K | -202.30%-3.28M | 1,084.83%1.11M | ---3.97M | 2,213.20%6.4M | 78.74%-233K |
-Change in receivables | -5.75%1.03M | 61.10%-467.11K | 316.78%1.29M | -19.88%-398K | -125.39%-2.46M | 33.82%1.1M | -149.58%-1.2M | ---596.88K | 92.84%-332K | 15.10%-1.09M |
-Change in inventory | 127.27%3K | -675.67%-409.63K | -110.18%-630 | -2,237.50%-171K | -265.69%-227K | 94.61%-11K | 26.09%-52.81K | --6.19K | 110.96%8K | 670.83%137K |
-Change in payables | 88.08%-500K | -151.66%-1.33M | 101.54%49.65K | -88.53%726K | 221.23%2.09M | -255.42%-4.19M | 196.76%2.58M | ---3.23M | 43.59%6.33M | 205.16%650K |
-Changes in other current assets | 12.28%-150K | 83.82%-33.65K | 25.40%-115.65K | -11.62%350K | -236.62%-97K | 67.12%-171K | -204.94%-208.02K | ---155.02K | --396K | --71K |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 44.44%-5K | 12.50%-7K | 53.33%-7K | -12.50%-9K | 77.78%-8K | -400.00%-15K | ||||
Interest received (cash flow from operating activities) | ||||||||||
Tax refund paid | 0 | 95.33%-6.81K | -52.36%-14.81K | 84.15%-13K | 66.67%-8K | 196.67%29K | -25.74%-145.72K | -9.72K | -13.89%-82K | 4.00%-24K |
Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating cash flow | 94.06%-270K | -190.20%-6.93M | 99.89%-4.1K | -113.26%-671K | 1.56%-1.71M | -119.85%-4.54M | 73.72%-2.39M | ---3.65M | 160.57%5.06M | 39.70%-1.74M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | --0 | 96.74%-3.31K | -77.12%90.69K | --0 | 212.50%9K | -221.88%-103K | 91.24%-101.57K | --396.43K | 59.07%-458K | -60.00%-8K |
Net intangibles purchase and sale | --0 | -1,168.82%-2.79M | -847.00%-2.08M | --0 | --0 | ---708K | ---220K | ---220K | ---- | ---- |
Net business purchase and sale | ---- | 2,042,470.79%1.82M | 2,270,560.67%2.02M | ---5K | ---- | ---- | -99.96%89 | --89 | ---- | ---- |
Advance cash and loans provided to other parties | ---- | ---1.78M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Interest received (cash flow from investment activities) | --0 | -38.69%70.15K | 120.80%56.15K | -96.15%1K | -93.94%2K | -63.33%11K | -38.77%114.43K | --25.43K | -83.01%26K | 83.33%33K |
Net changes in other investments | ---- | ---- | ---- | ---- | ---- | ---- | 2,622.37%277.56K | --6.56K | --0 | --0 |
Investing cash flow | --0 | -3,914.67%-2.69M | -914.75%-1.7M | 99.07%-4K | -848.00%-187K | -397.40%-800K | 109.01%70.51K | --208.51K | 55.74%-432K | 92.31%25K |
Financing cash flow | ||||||||||
Net common stock issuance | ---- | --1M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Increase or decrease of lease financing | 87.30%-16K | 12.41%-432.06K | 58.91%-127.06K | -238.71%-86K | 23.77%-93K | -1.61%-126K | 7.64%-493.27K | ---309.27K | 114.76%62K | -130.19%-122K |
Issuance fees | ---- | ---5.25K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Interest paid (cash flow from financing activities) | ---- | 35.52%-27.72K | ---- | ---- | ---- | ---- | 8.02%-42.99K | ---- | ---- | ---- |
Financing cash flow | 87.30%-16K | 199.76%534.96K | 338.45%839.96K | -238.71%-86K | 23.77%-93K | -1.61%-126K | -106.74%-536.26K | ---352.26K | -99.25%62K | -102.00%-122K |
Net cash flow | ||||||||||
Beginning cash position | -90.90%909K | -22.21%9.99M | -87.14%1.77M | -72.13%2.53M | -58.59%4.52M | -22.21%9.99M | -12.95%12.84M | --13.78M | -38.39%9.09M | -12.63%10.92M |
Current changes in cash | 94.77%-286K | -218.36%-9.08M | 77.23%-863.02K | -116.22%-761K | -8.51%-1.99M | -184.64%-5.47M | -49.32%-2.85M | ---3.79M | 553.24%4.69M | -156.59%-1.83M |
End cash Position | -86.22%623K | -90.90%908.58K | -90.90%908.58K | -87.14%1.77M | -72.13%2.53M | -58.59%4.52M | -22.21%9.99M | --9.99M | 0.45%13.78M | -42.25%9.09M |
Free cash flow | 94.96%-270K | -259.78%-9.74M | 41.78%-2.02M | -114.58%-671K | 2.52%-1.7M | -155.15%-5.35M | 73.56%-2.71M | ---3.47M | 148.59%4.6M | 39.53%-1.74M |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.